Lexicon Pharmaceuticals (LXRX) Revenue Growth (5y) (2015 - 2025)
Lexicon Pharmaceuticals (LXRX) Revenue Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn |
| 10 | Lexicon Pharmaceuticals | 886.53 Mn | 715.87 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 94.17% |
| Jun 30, 2025 | 309.72% |
| Mar 31, 2025 | -30.88% |
| Dec 31, 2024 | 24.93% |
| Sep 30, 2024 | -63.91% |
| Jun 30, 2024 | 13.88% |
| Mar 31, 2024 | -14.83% |
| Dec 31, 2023 | -46.25% |
| Sep 30, 2023 | -52.87% |
| Jun 30, 2023 | -53.78% |
| Jun 30, 2022 | -68.93% |
| Dec 31, 2020 | -72.53% |
| Jun 30, 2020 | -41.85% |
| Mar 31, 2020 | 34.88% |
| Dec 31, 2019 | -16.49% |
| Sep 30, 2019 | 268.81% |
| Jun 30, 2019 | 4.93% |
| Mar 31, 2019 | 54.51% |
| Dec 31, 2018 | 64.67% |
| Sep 30, 2018 | 96.46% |